Clinical Trials Logo

Risk Factor, Cardiovascular clinical trials

View clinical trials related to Risk Factor, Cardiovascular.

Filter by:

NCT ID: NCT03921853 Completed - Obesity Clinical Trials

Resistance Training in Patients With Morbid Obesity

ExinMO
Start date: January 1, 2018
Phase: N/A
Study type: Interventional

The researchers will conduct a study for avoiding the metabolic syndrome in morbid obese patients. Thus, the aim of the present will be determine the effects of a resistance training programme (RT) in preventing or attenuating metabolic syndrome (MetS) in patients with morbid obesity. A second aim will be report the prevalence of non-responders in terms of improvements in MetS markers and other co-variables considered.

NCT ID: NCT03698786 Completed - Physical Activity Clinical Trials

Exercise Effects on Appetite-regulating Hormones and Cardiovascular Risk Factors

Start date: May 24, 2017
Phase:
Study type: Observational

The aim of this study is to examine the effect of a single bout of moderate exercise, standardized breakfast and buffet meal on appetite-related hormones, type two diabetes and cardiovascular risk factors with a comparison between healthy South Asian and white European men. It is of interest to see if any factor differences occur in appetite-regulating hormones and cardiovascular disease risk factors whilst exercising. If so strategies may be used to alter regulation in diet and exercise to reduce risk cardiovascular disease as this is the number one cause of death globally.

NCT ID: NCT03510494 Completed - Physical Activity Clinical Trials

The Svendborg-project

CHAMPS-DK
Start date: August 2008
Phase: N/A
Study type: Interventional

The main aim of this study is to describe differences in development of health and motor performance over time in relation to type of school and other background variables.

NCT ID: NCT03400800 Completed - Clinical trials for Risk Factor, Cardiovascular

Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol

ORION-11
Start date: November 1, 2017
Phase: Phase 3
Study type: Interventional

This is a Phase III, placebo-controlled, double-blind, randomized study in participants with ASCVD or ASCVD-Risk equivalents and elevated LDL-C despite maximum tolerated dose of LDL-C lowering therapies to evaluate the efficacy, safety, and tolerability of subcutaneous (SC) inclisiran injection(s). The study will be an international multicenter study (non-United States).

NCT ID: NCT03377582 Completed - Cardiac Disease Clinical Trials

Virtual Reality Based-therapy Applied to Physical Therapy in Cardiology.

Start date: December 19, 2017
Phase: N/A
Study type: Interventional

The aim of this study is to investigate engagement, motivation, and the barriers to adherence of virtual reality based therapy (VRBT) in patients with cardiac diseases and risk factors to the development of cardiac diseases. In addition, to investigate autonomic and hemodynamic responses of VRBT in comparison with conventional therapy (CT). To do this, patients with cardiac diseases or risk factors will be invited to perform CT or VRBT+CT. They will be submitted to an initial evaluation, and then will be random allocated to 12 weeks of intervention and to a final evaluation. The primary outcomes includes engagement, motivation, barriers and adherence in the 12 previous weeks using questionnaire, after 12 weeks of the intervention and after 12 weeks of the final intervention program. Hemodynamic and autonomic responses will be considered the secondary outcomes being evaluated before, during and after a session at the first, sixth and twelfth week.

NCT ID: NCT03329729 Completed - Quality of Life Clinical Trials

PLATOREL® STUDY IN CARDIOVASCULAR RISĪš ASSESMENT

PLATINUM
Start date: February 1, 2018
Phase:
Study type: Observational

Dyslipidemias are a major risk factor for the onset of cardiovascular disease, while early diagnosis and appropriate treatment approaches significantly reduce cardiovascular morbidity and mortality. The aim is to provide revised Greek guidelines for the diagnosis and treatment of dyslipidaemias. The lipids of the human body are cholesterol (it is used to synthesize cell membranes, adrenal hormones and gonads and is a component of bile) and triglycerides (used as a fuel and as a storage of energy in adipose tissue). Dyslipidemias are disorders (quantitative or qualitative) of the metabolism of lipoprotein particles [low density lipoproteins (LDL), chylomic, high density lipoproteins (HDL), very low density lipoproteins (VLDL)] that carry lipids into the body. Primary prevention in subjects aged 40-65 years with no known clinical atherosclerotic disease and without diabetes or chronic renal disease should evaluate the likelihood of a fatal cardiovascular event over the next 10 years. For this purpose, it is recommended to use the Greek version of the SCORE of the Hellenic Heart SCORE.

NCT ID: NCT03282747 Completed - Clinical trials for Venous Thromboembolism

Distribution of Risk Factors for Venous Thromboembolism in Blood Donors

ANEMONE
Start date: July 15, 2017
Phase:
Study type: Observational

Venous thromboembolism occurs with an incidence of about 1 per 1000 per year in adults . The main consequences are death, recurrence, post-thrombotic syndrome and major bleeding due to anticoagulation. Mortality rates are lower among patients with idiopathic venous thrombosis and higher among those in whom thrombosis occurs in the presence of cancer. The risk increases with the age for unclear reasons. There are also differences in the incidence according to ethnicity; however, data in subjects of European ancestry are scarce. Several studies have documented an association between thrombosis and ABO group. Specifically, non-O blood groups have a higher risk of myocardial infarction, angina, peripheral vascular disease, cerebral ischemia and venous thromboembolism than O. While there are numerous studies carried out in patients who have already shown thromboembolic events, data on the incidence of risk factors in the healthy population are completely inadequate. Understanding the risk factors for venous thrombosis is necessary to maximize the prevention of this disease in individuals and groups of high-risk patients . For this purpose a self-administered questionnaire will be used. Data obtained by blood donors on exposure to risk factors will be used to set up a clinical score to validate in future studies to carry out in patients with VTE.

NCT ID: NCT03236597 Completed - Sedentary Lifestyle Clinical Trials

Assessing the Effects Of Treadmill On LPA, Sitting Time, and Cardiovascular Risk

Start date: October 5, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to: 1. Evaluate the relative efficacy of a treadmill desk intervention on light physical activity and sitting behaviors at work over four weeks; 2. Evaluate the relative efficacy of a treadmill desk intervention on the cardiovascular risk profiles (blood pressure, body weight, body fat percentage) over a four-week period.

NCT ID: NCT03219996 Completed - Clinical trials for Risk Factor, Cardiovascular

Risk Factors for Predictors of In-hospital Death in Acute Fulminant Myocarditis

Start date: January 1, 2016
Phase: N/A
Study type: Observational

The investigators performed a retrospective, single-center observational study, and the participants with acute fulminant myocarditis were included.Then, the investigator analyzed the risk factors of in-hospital death in these participants with acute fulminant myocarditis.

NCT ID: NCT03154502 Completed - Dietary Habits Clinical Trials

Sodium Intake in Ecuadorian Population

Start date: March 1, 2015
Phase: N/A
Study type: Observational

This study is aim to determine the sodium intake in Ecuadorian population that is an unknown information at present. For that, 24h urine samples will be collected from 130 subjects working either at tue USFQ or HDLV to measure sodium excretion.